Series B - Alebund Pharmaceuticals - May 9, 2021 Funding Round Profile - Cointime

Bitcoin $79,582.73 +4.01%
Ethereum $3,202.45 +4.90%
BNB $635.47 +1.40%
Optimism $1.67 +1.16%
Arbitrum $0.64 +4.55%
Solana $205.40 +1.01%
Polygon $0.41 +5.48%
Cosmos $5.25 +9.80%
Avalanche $31.97 +8.11%

Bitcoin $79,582.73 +4.01%
Ethereum $3,202.45 +4.90%
BNB $635.47 +1.40%
Optimism $1.67 +1.16%
Arbitrum $0.64 +4.55%
Solana $205.40 +1.01%
Polygon $0.41 +5.48%
Cosmos $5.25 +9.80%
Avalanche $31.97 +8.11%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail